Strategikon Pharma, Inc. — Form D
Strategikon Pharma, Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-15. The offering totals $1.0M. Industry: Business Services.
Offering
- Filed: 2017-11-15
- Form: D
- Accession: 0001722200-17-000001
- Industry: Business Services
- Exemptions: 04, 06b
- Total offering: $1.0M
- Remaining: $1.0M
- Minimum investment: $20K
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-298794
Issuer
- Name: Strategikon Pharma, Inc.
- CIK: 0001722200
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1 Sansome Street, 35th Floor PMB #40621, San Francisco, CA, 94104
- Phone: (609) 529-7806
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Paulo Carvalho | Director | San Francisco, CA |
| Rob Hess | Director | San Francisco, CA |
| Anca Copaescu | Director | San Francisco, CA |
| Anca Copaescu | Executive Officer | San Francisco, CA |
| Anca Copaescu | Promoter | San Francisco, CA |
| Debra Apruzzese | Director | San Francisco, CA |
| Chris Codeanne | Director | San Francisco, CA |
| Paulo Carvalho | Executive Officer | San Francisco, CA |
| Paulo Carvalho | Promoter | San Francisco, CA |
| Vincent Lepreux | Director | San Francisco, CA |
| Mark Weinstein | Director | San Francisco, CA |
| Mark Weinstein | Executive Officer | San Francisco, CA |
| Nathanael Lentz | Director | Spokane, WA |
| Mark Di Ianni | Director | Valley Falls, NY |
| Mark Di Ianni | Executive Officer | Valley Falls, NY |
| Mark Di Ianni | Promoter | Valley Falls, NY |
Other filings by this issuer (2)
More